{
    "clinical_study": {
        "@rank": "144523", 
        "arm_group": [
            {
                "arm_group_label": "Acetaminophen", 
                "arm_group_type": "No Intervention", 
                "description": "Patients from this arm will receive a dosis of acetaminophen (500 mg/8 hours) while PRP treatment lasts."
            }, 
            {
                "arm_group_label": "Intra-articular injection of PRP", 
                "arm_group_type": "Experimental", 
                "description": "Patients from this arm will receive 3 intra-articular knee injections of autologous platelet-rich plasma, one injection every two weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to test whether the platelet-rich plasma (PRP)intra-articular\n      injection therapy is effective as an alternative treatment option in patients with mild knee\n      osteoarthritis within a controlled randomized study. The investigators will evaluate\n      patients outcome in level of pain and  quality of life at 3, 6 and 12 months follow up. The\n      investigators will also analyze  the biochemical environment in patient's joint before and\n      after the treatment.\n\n      The study will be complemented with in vitro experiments of human osteoarthritic cartilage\n      explants culture (and treated with PRP) for histological and gene expression assays.\n\n      PRP intra-articular injections therapy is effective in patients with mild knee\n      osteoarthritis by modifying the biochemical joint environment and cartilage regeneration\n      capability."
        }, 
        "brief_title": "In Vivo and in Vitro Evaluation of PRP Therapy", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Osteoarthritis Grade I and II (Kellgren-Lawrence Scale)", 
        "condition_browse": {
            "mesh_term": "Osteoarthritis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Older than 18 years old\n\n          -  Patients who haven't received steroids injection or medical treatment 1 month before\n             the study\n\n          -  Patients with knee osteoarthritis grade I and II (Kellgren-Lawrence scale)\n\n          -  Indistinct gender\n\n          -  Patients who accept to participate in the study with previous signed informed consent\n\n        Exclusion Criteria:\n\n          -  Patients with knee osteoarthritis grade III and IV (Kellgren-Lawrence scale)\n\n          -  Patients with prosthesis\n\n          -  Pregnancy\n\n          -  Patients with rheumatic diseases\n\n          -  Patients with diabetes, hepatic diseases, coagulopathy, cardiovascular diseases,\n             immunosuppression, infections\n\n          -  Patients taking anticoagulants\n\n          -  Patients with concentrations of hemoglobin under 11 g/dL and platelets under\n             150,000/uL"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782885", 
            "org_study_id": "BI13-001"
        }, 
        "intervention": {
            "arm_group_label": "Intra-articular injection of PRP", 
            "description": "Patients from this arm will receive 3 intra-articular knee injections of autologous platelet-rich plasma, one injection every two weeks.", 
            "intervention_name": "Intra-articular injection of PRP", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": "Acetaminophen"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Osteoarthritis", 
            "Platelet-Rich Plasma", 
            "Intra-articular", 
            "Injection"
        ], 
        "lastchanged_date": "January 31, 2014", 
        "location": {
            "contact": {
                "email": "mario.simental@gmail.com", 
                "last_name": "Mario A. Simental, MSc"
            }, 
            "contact_backup": {
                "email": "vilchez.doctor@gmail.com", 
                "last_name": "Felix Vilchez, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Monterrey", 
                    "country": "Mexico", 
                    "state": "Nuevo Le\u00f3n", 
                    "zip": "64460"
                }, 
                "name": "Hospital Universitario Dr. Jos\u00e9 E. Gonz\u00e1lez"
            }, 
            "investigator": [
                {
                    "last_name": "Mario A. Simental, MSc", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Felix Vilchez, PhD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "In Vivo and in Vitro Evaluation of the Platelet-rich Plasma Treatment in Osteoarthritis.", 
        "other_outcome": {
            "description": "The SF-12v2 Health Survey will be performed on patients who received the treatment at 0, 3, 6 and 12 months after treatment finished.", 
            "measure": "Change in SF-12v2 Health Survey", 
            "safety_issue": "No", 
            "time_frame": "0, 3, 6, 12 months"
        }, 
        "overall_contact": {
            "email": "vilchez.doctor@gmail.com", 
            "last_name": "Felix Vilchez, PhD", 
            "phone": "+52 (81) 8346 2310"
        }, 
        "overall_official": [
            {
                "affiliation": "Universidad Aut\u00f3noma de Nuevo Le\u00f3n, Facultad de Medicina", 
                "last_name": "Mario A. Simental, MSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universidad Aut\u00f3noma de Nuevo Le\u00f3n, Hospital Universitario Dr. Jos\u00e9 E. Gonz\u00e1lez", 
                "last_name": "Felix Vilchez, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Universidad Aut\u00f3noma de Nuevo Le\u00f3n, Facultad de Medicina", 
                "last_name": "Herminia G Mart\u00ednez, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Mexico: Research Ethics Committee from Facultad de Medicina and Hospital Universitario Dr. Jose Eleuterio Gonzalez", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The WOMAC evaluation will be performed on patients who received the treatment at 0, 1 1/2, 3, 6 and 12 months after treatment finished.", 
            "measure": "Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC)", 
            "safety_issue": "No", 
            "time_frame": "0, 1 1/2, 3, 6, 12 months"
        }, 
        "reference": [
            {
                "PMID": "22513879", 
                "citation": "Spakov\u00e1 T, Rosocha J, Lacko M, Harvanov\u00e1 D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012 May;91(5):411-7. doi: 10.1097/PHM.0b013e3182aab72."
            }, 
            {
                "PMID": "22203046", 
                "citation": "Filardo G, Kon E, Pereira Ruiz MT, Vaccaro F, Guitaldi R, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012 Oct;20(10):2082-91. Epub 2011 Dec 28."
            }, 
            {
                "PMID": "21856929", 
                "citation": "van Buul GM, Koevoet WL, Kops N, Bos PK, Verhaar JA, Weinans H, Bernsen MR, van Osch GJ. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med. 2011 Nov;39(11):2362-70. doi: 10.1177/0363546511419278. Epub 2011 Aug 19."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782885"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Universitario Dr. Jose E. Gonzalez", 
            "investigator_full_name": "Mario Alberto Simental Mendia, M Sc, Principal Investigator", 
            "investigator_title": "M. Sc.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The VAS evaluation will be performed on patients who received the treatment at 0, 1 1/2, 3, 6 and 12 months after treatment finished.", 
            "measure": "Change in Visual Analog Scale (VAS)", 
            "safety_issue": "No", 
            "time_frame": "0, 1 1/2, 3, 6, 12 months"
        }, 
        "source": "Hospital Universitario Dr. Jose E. Gonzalez", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital Universitario Dr. Jose E. Gonzalez", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}